ZYBT
Zhengye Biotechnology Holding Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.45
+3.57%Margins
Gross margin
18.3%
EBITDA margin
-40.7%
EBIT margin
-63.6%
Net margin
-65.3%
FCF margin
17.5%
-37.2%
Return on equity
-21.3%
Return on assets
-27.9%
Return on invested capital
0.33x
Asset turnover
$2.9M
Cash from operations
$0.26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025